CN102070518B - Synthesis of derivatives of substituted pyridine and azaindole - Google Patents

Synthesis of derivatives of substituted pyridine and azaindole Download PDF

Info

Publication number
CN102070518B
CN102070518B CN 201110025308 CN201110025308A CN102070518B CN 102070518 B CN102070518 B CN 102070518B CN 201110025308 CN201110025308 CN 201110025308 CN 201110025308 A CN201110025308 A CN 201110025308A CN 102070518 B CN102070518 B CN 102070518B
Authority
CN
China
Prior art keywords
alkyl
lithium
butyl lithium
azaindole
substituted pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110025308
Other languages
Chinese (zh)
Other versions
CN102070518A (en
Inventor
刘兆刚
丛欣
马玉恒
赵欣
黄伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Simcere Pharmaceutical Co Ltd
Original Assignee
Jiangsu Simcere Pharmaceutical R&D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Simcere Pharmaceutical R&D Co Ltd filed Critical Jiangsu Simcere Pharmaceutical R&D Co Ltd
Priority to CN 201110025308 priority Critical patent/CN102070518B/en
Publication of CN102070518A publication Critical patent/CN102070518A/en
Application granted granted Critical
Publication of CN102070518B publication Critical patent/CN102070518B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

The invention relates to the synthesis of derivatives of substituted pyridine and azaindole. A substituted pyridine derivative is obtained by using 4-chlorin-2- pyridine carboxylic acid as an initial raw material to form 3-position carbanion under the action of a metal lithium compound and reacting the 3-position carbanion with various electrophilic reagents.

Description

Synthesizing of substituted pyridines and 7-azaindole derivatives
Technical field
The present invention relates to the synthetic of substituted pyridines and 7-azaindole derivatives.
Background technology
Preparation 3 at present, the method for 4-dichloropyridine acid amides mainly contains following two kinds of methods: Journal of Medicinal Chemistry, 2009,52 (5), 1251-1254
Figure BDA0000044981200000011
The raw material 3 that Scheme 1 uses, 4-dichloropyridine and the silica-based isocyanic ester of reagent front three cost an arm and a leg, and production cost is higher; It is expensive 3 that Scheme 2 has not only used, and the 4-dichloropyridine is a raw material, and be difficult to close with product polarity of by product that generates removed.
Therefore, be necessary to select a kind of method of inexpensive, easy purifying end product newly.
Summary of the invention:
The present invention is a starting raw material with the inexpensive 4-chloro-2-VPP that has got, through the effect of metal lithiumation thing, with the electrophilic reagent reaction, forms 3 substituted pyridine compounds.
The method for preparing substituted pyridines of the present invention may further comprise the steps:
Figure BDA0000044981200000021
Wherein: X represents halogen, C 1-C 4Alkyl;
Said step is for being raw material with 4-chloro-2-VPP, under the effect of organo-metallic lithiumation thing, and contains halogen or C 1-C 4The electrophilic reagent reaction of alkyl obtains compound I I.
Said organo-metallic lithiumation thing is selected from n-Butyl Lithium, s-butyl lithium, tert-butyl lithium, lithium diisopropyl amido, 2,2,6,6-tetramethyl piperidine lithium.
Said electrophilic reagent is selected from Br 2, I 2, Sesquichloratum, difluoro monochlorethane, halohydrocarbon, carboxylic acid halides, contain C 1-C 4The ester of alkyl or aldehyde ketone compound.
Said halogen refers to F, Cl, Br, I, preferred Cl, Br, I.
Beneficial effect of the present invention is:
One, route is simple, and reaction reagent is commonly used, and production cost is relatively low;
Two, product is single, and purifying is easy.
Embodiment:
Content of the present invention is done further to set forth through following embodiment and accompanying drawing, but does not limit the scope of the invention.
Embodiment 1: preparation 3,4-dichloropyridine acid amides (1)
Figure BDA0000044981200000022
At Ar 2Under the protection, (12g 76.2mmol) is dissolved among the anhydrous THF of 250ml, adds TMEDA (Tetramethyl Ethylene Diamine then with 4-chloro-2-VPP; 18.6g 159.9mmol), stirring at room is positioned over and stirs cooling in the cryotrap after all dissolving clearly; After temperature drops to-78 ℃, stir 0.5h, slowly drip n-BuLi (64ml, 2.5M; 159.9mmol), after dropwising, low temperature stirs 1h, drips the THF solution of Sesquichloratum (228mmol) then; Dropping time 1h drips afterreaction 1h, after temperature rises to room temperature, adds saturated aqueous ammonium chloride and Sulfothiorine cancellation reaction; 2N HCl transfers to pH=3, ethyl acetate extraction, and anhydrous sodium sulfate drying, solvent evaporated obtains compound S 2 and directly is used for next step.
S2 is joined in the single port bottle of 200ml, add thionyl chloride then, after stirring at room was dissolved clearly, elevated temperature was to refluxing; Reaction 2h boils off thionyl chloride, adds the 50ml ether; Use 50ml ammoniacal liquor, ice bath stirs 30min down, uses ethyl acetate extraction again; Anhydrous sodium sulfate drying concentrates back column chromatography (PE/EA=1/1) and obtains S2 4.6g, yield 32%.
Embodiment 2: preparation 3-iodo-4-chloro-picolinamide (2)
Figure BDA0000044981200000031
(12g 76.2mmol) is dissolved among the anhydrous THF of 250ml, and according to the method for embodiment 1, organo-metallic lithiumation thing is selected n-Butyl Lithium for use, and (64ml, 2.5M 159.9mmol), add I with 4-chloro-2-VPP 2(38.6g 152.4mmol), obtains 2 (4.6g, yield 31%).
Product to making is tested, and the result is following:
1H-NMR(500M,DMSO-d 6)δ8.44(d,1H),7.95(s,2H),7.68(d,1H)ppm。

Claims (3)

1. method for preparing substituted pyridines, its characteristic may further comprise the steps:
Figure 2011100253088100001DEST_PATH_IMAGE001
Wherein: X represents halogen, C 1-C 4Alkyl;
Said step is for being raw material with 4-chloro-2-VPP, under the effect of organo-metallic lithiumation thing, and contains halogen or C 1-C 4The electrophilic reagent reaction of alkyl obtains compound I I.
2. preparation method as claimed in claim 1 is characterized in that: organo-metallic lithiumation thing is selected from n-Butyl Lithium, s-butyl lithium, tert-butyl lithium, lithium diisopropyl amido, 2,2,6,6-tetramethyl piperidine lithium.
3. preparation method as claimed in claim 1, it is characterized in that: electrophilic reagent is selected from Br 2, I 2, Sesquichloratum, difluoro monochlorethane, carboxylic acid halides, contain C 1-C 4The ester of alkyl or aldehyde ketone compound.
CN 201110025308 2011-01-24 2011-01-24 Synthesis of derivatives of substituted pyridine and azaindole Active CN102070518B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110025308 CN102070518B (en) 2011-01-24 2011-01-24 Synthesis of derivatives of substituted pyridine and azaindole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110025308 CN102070518B (en) 2011-01-24 2011-01-24 Synthesis of derivatives of substituted pyridine and azaindole

Publications (2)

Publication Number Publication Date
CN102070518A CN102070518A (en) 2011-05-25
CN102070518B true CN102070518B (en) 2012-05-02

Family

ID=44029299

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110025308 Active CN102070518B (en) 2011-01-24 2011-01-24 Synthesis of derivatives of substituted pyridine and azaindole

Country Status (1)

Country Link
CN (1) CN102070518B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85107182A (en) * 1985-09-27 1987-04-08 弗·哈夫曼-拉罗切有限公司 Process for preparing monoamide derivatives of ethylenediamine
WO2008079873A3 (en) * 2006-12-20 2008-10-02 Bristol Myers Squibb Co Thiazolyl compounds useful as kinase inhibitors
CN101535264A (en) * 2006-11-08 2009-09-16 百时美施贵宝公司 Pyridinone compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85107182A (en) * 1985-09-27 1987-04-08 弗·哈夫曼-拉罗切有限公司 Process for preparing monoamide derivatives of ethylenediamine
CN101535264A (en) * 2006-11-08 2009-09-16 百时美施贵宝公司 Pyridinone compounds
WO2008079873A3 (en) * 2006-12-20 2008-10-02 Bristol Myers Squibb Co Thiazolyl compounds useful as kinase inhibitors

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Bieniek, Adam
Epsztajn, Jan
Epsztajn, Jan;Bieniek, Adam;Kowalska, Justyna A..Application of organolithium and related reagents in synthesis. Part 9. Synthesis and metalation of 4-chloropicolin- and 2-chloroisonicotinanilides. A useful method for preparation of 2,3,4-trisubstituted pyridines.《Tetrahedron》.1991,1697-706. *
Kowalska, Justyna A..Application of organolithium and related reagents in synthesis. Part 9. Synthesis and metalation of 4-chloropicolin- and 2-chloroisonicotinanilides. A useful method for preparation of 2,3,4-trisubstituted pyridines.《Tetrahedron》.1991,1697-706.
Mitsuhashi, Keiryo.Kinetic study on the conversion of pyridine- and quinolinecarboxylic acids to the corresponding trichloromethyl compounds.《Journal of Heterocyclic Chemistry》.1978,893-6.
Schroeder Gretchen M. et al.Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4- ethoxy-1-(4-fluorophenyl)-2-oxo-1
Schroeder, Gretchen M. et al.Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4- ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily.《Journal of Medicinal Chemistry》.2009,1251-1254. *
Takahashi, Kazuyuki
Takahashi, Kazuyuki;Takeda, Koichi;Mitsuhashi, Keiryo.Kinetic study on the conversion of pyridine- and quinolinecarboxylic acids to the corresponding trichloromethyl compounds.《Journal of Heterocyclic Chemistry》.1978,893-6. *
Takeda, Koichi

Also Published As

Publication number Publication date
CN102070518A (en) 2011-05-25

Similar Documents

Publication Publication Date Title
CN104513145B (en) The fluoro-4-difluoro of 2,3,5-tri-(3,4,5-trifluoro-benzene phenolic group) methyl-benzaldehyde and synthetic method thereof and in the application of preparing in liquid-crystal compounds
CN102285984A (en) Preparation method of (2R, 3R, 11bR)-dihydrotetrabenazine and relevant compounds
CN102977009B (en) A kind of synthetic method of 2-trifluoromethyl-3-fluorine pyridine
CN103833560B (en) (S) preparation method of-5-chloro-α-cyclopropyne base-2-amino-α-trifluoromethyl benzyl alcohol
RU2014131451A (en) METHODS FOR PRODUCING 4-AMINO-3-CHLOR-6- (4-CHLOR-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylate methyl
CN102617455B (en) Preparation method of pyridoxal or pyridoxal hydrochloride
CN103288801B (en) A kind of preparation method of high-purity esomeprazole sodium
CN102617434A (en) Process for preparing Vildagliptin by one-pot method
CN102070518B (en) Synthesis of derivatives of substituted pyridine and azaindole
CN103787963A (en) Efficient preparation of 4-dimethylaminopyridine
CN106188040A (en) A kind of Fevipiprant and the preparation method of intermediate thereof
CN102898360A (en) Synthesis of 3, 5-dibromo-4-iodopyridine
CN103880756B (en) The preparation method of a kind of Azilsartan intermediate
CN103724275A (en) 4-nitroimidazole and preparation method thereof
CN103086818B (en) Method by 2-hydroxyl the third dicyan synthesis Alpha-hydroxy amide
CN109574938B (en) Method for synthesizing rosuvastatin sodium
CN104262248A (en) Method for preparing 5-substituted 4,4-difluoro-3,5-dihydrocarboxylic acid and metal salts thereof
CN103601671A (en) Preparation method of iodo trifluoro methyl pyridine
CN103664765A (en) Preparation method of 2-amino-3-bromopyridine
CN103965100B (en) A kind of method preparing imidazolinone herbicide intermediate
CN103664960A (en) Preparation method for Ponatinib
CN103965109B (en) A kind of method of synthesizing codamine
CN102336738A (en) Synthesis method of 2-thiopheneethamine
CN104402859A (en) Preparation method for 3-(piperidine-4-yl)-pyridazine
CN105153152B (en) A kind of synthetic method of imidazoles fused ring compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18

Applicant after: JIANGSU SIMCERE PHARMACEUTICAL R & D Co.,Ltd.

Address before: 210042 -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, 669

Applicant before: JIANGSU SIMCERE PHARMACEUTICAL R & D Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NANJING XINNUOTHAI PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: JIANGSU SIMCERE PHARMACEUTICAL RESEARCH COMPANY LIMITED

Effective date: 20140526

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20140526

Address after: 210042, -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, Nanjing 699

Patentee after: NANJING SIMNOVTEC PHARMACEUTICAL CO.,LTD.

Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18

Patentee before: JIANGSU SIMCERE PHARMACEUTICAL R & D Co.,Ltd.

TR01 Transfer of patent right

Effective date of registration: 20200602

Address after: Room 539, building F6, No.9, Weidi Road, Qixia District, Nanjing City, Jiangsu Province

Patentee after: NANJING NORATECH PHARMACEUTICALS Co.,Ltd.

Address before: 210042, -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, Nanjing 699

Patentee before: NANJING SIMNOVTEC PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230504

Address after: No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing City, Jiangsu Province

Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd.

Address before: 210046 room 539, F6 building, No.9, Weidi Road, Qixia District, Nanjing City, Jiangsu Province

Patentee before: NANJING NORATECH PHARMACEUTICALS Co.,Ltd.

TR01 Transfer of patent right